Tech Company Financing Transactions
AmacaThera Funding Round
On 1/15/2019, AmacaThera landed $2.4 million in Seed financing from Sprout BioVentures, Viva Ventures Biotech and Grey Sky Venture Partners.
Transaction Overview
Company Name
Announced On
1/15/2019
Transaction Type
Venture Equity
Amount
$2,449,512
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance its drug delivery platform technology through Phase I clinical proof-of-concept.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
160 College St. 530
Toronto ON, M5S3E1
Canada
Toronto ON, M5S3E1
Canada
Phone
Website
Email Address
Overview
AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications. Based on the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and pharmaceuticals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Cooke
Browse more venture capital transactions:
Prev: 1/15/2019: Syncurity venture capital transaction
Next: 1/16/2019: alwaysAI venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs